-
Functional Areas
- Principal Recipient Start-Up
-
Legal Framework
- Overview
- Project Document
-
The Grant Agreement
- UNDP-Global Fund Grant Regulations
- Grant Confirmation
- Grant Confirmation: Face Sheet
- Grant Confirmation: Conditions
- Grant Confirmation: Conditions Precedent (CP)
- Grant Confirmation: Special Conditions (SCs)
- Grant Confirmation: Schedule 1, Integrated Grant Description
- Grant Confirmation: Schedule 1, Performance Framework
- Grant Confirmation: Schedule 1, Summary Budget
- Implementation Letters and Performance Letters
- Agreements with Sub-recipients
- Agreements with Sub-sub-recipients
- Signing Legal Agreements and Requests for Disbursement
- Language of the Grant Agreement and other Legal Instruments
- Amending Legal Agreements
- Other Legal and Implementation Considerations
- Legal Framework for Other UNDP Support Roles
-
Health Product Management
- Overview - Health Product Management
- UNDP Quality Assurance Policy
- Product Selection
- Quantification and Forecasting
- Supply Planning of Health Products
-
Sourcing and regulatory aspects
- Global Health Procurement Center (GHPC)
- Development of List of Health Products
- Development of the Health Procurement Action Plan (HPAP)
- Health Procurement Architecture
- Local Procurement of health products
- Procurement of Pharmaceutical Products
- Procurement of non-pharmaceutical Health Products
- Other Elements of the UNDP Procurement Architecture
- Submission of GHPC CO Procurement Request Form
- Guidance on donations of health products
- International freight, transit requirements and use of INCOTERMS
- Inspection and Receipt
- Storage
- Inventory Management
- Distribution
- Quality monitoring of health products
- Waste management
- Rational use
- Pharmacovigilance
- Risk Management for PSM of health products
- Compliance with the Global Fund requirements
- UNDP Health PSM Roster
-
Financial Management
- Overview
- Grant-Making and Signing
- Grant Implementation
- Sub-recipient Management
- Grant Reporting
- Grant Closure
- CCM Funding
- Import duties and VAT / sales tax
-
Monitoring and Evaluation
- Overview
- Differentiation Approach
- Monitoring and Evaluation Components of Funding Request
- Monitoring and Evaluation Components of Grant Making
- M&E Components of Grant Implementation
- Sub-Recipient Management
- Grant Reporting
-
Capacity development and transition, strengthening systems for health
- Overview
- Interim Principal Recipient of Global Fund Grants
- A Strategic Approach to Capacity Development
- Resilience and Sustainability
- Legal and Policy Enabling Environment
- Functional Capacities
- Capacity Development and Transition
- Transition
- Capacity Development Objectives and Transition Milestones
- Capacity Development Results - Evidence From Country Experiences
- Capacity development and Transition Planning Process
- Capacity Development and Transition - Lessons Learned
-
Risk Management
- Overview
- Introduction to Risk Management
-
Risk Management in the Global Fund
- Global Fund Risk Management Framework
- Local Fund Agent
- Challenging Operating Environment (COE) Policy
- Additional Safeguard Policy
- Global Fund Risk Management Requirements for PRs
- Global Fund Risk Management Requirements During Funding Request
- Global Fund Review of Risk Management During Grant Implementation
- Risk management in UNDP
- Risk Management in UNDP-managed Global Fund projects
- UNDP Risk Management Process
- Risk management in crisis settings
- Audit and Investigations
- Human rights, key populations and gender
- Human resources
-
Grant closure
- Overview
- Terminology and Scenarios for Grant Closure Process
-
Steps of Grant Closure Process
- 1. Global Fund Notification Letter 'Guidance on Grant Closure'
- 2. Preparation and Submission of Grant Close-Out Plan and Budget
- 3. Global Fund Approval of Grant Close-Out Plan
- 4. Implementation of Close-Out Plan and Completion of Final Global Fund Requirements (Grant Closure Period)
- 5. Operational Closure of Project
- 6. Financial Closure of Project
- 7. Documentation of Grant Closure with Global Fund Grant Closure Letter
Storage
Health products are stored in various storage points along the national supply chain: they are usually stored in the national Central Medical Store (CMS) [1] after reception in-country, before being distributed to intermediate stores (regional and district stores), and then to health facilities where they are dispensed to patients. Health products for use in clinical laboratories may be managed through a dedicated national supply chain system due to temperature requirements and limited shelf-life of many reagents and consumables. Sometimes health products may even be delivered to the community level through community health workers or through non-government organisations (NGOs).
Considering the number of public health facilities storing health products in a country, it is beyond UNDP’s reach to guarantee good storage practices in all health facilities of a country. However, when working through the Ministry of Health supply chain (Central Medical Stores CMS, regional/district stores, health facilities), UNDP, as a development partner, should support the MoH in achieving the standards for good storage practices. This can be achieved through technical assistance and financial support, to the extent allowed by budget availability.
Using funds available under the Global Fund grant(s), UNDP COs can support activities that will help government and/or non-governmental organisations to achieve standards for GSP (e.g., QA and GSP training; procurement of temperature recording devices; procurement and installation of cooling units; etc). These activities should be primarily implemented at central level, and then cascaded down the supply chain to the extent the budget allows. GF grant funds may not be used to support system strengthening of private sector facilities.
[1] The term “Central Medical Stores” (CMS) describes the national warehouse system that is mandated by the government to manage health products. The CMS is, generally, responsible for the procurement, storage, and distribution of pharmaceutical products and other health products such as HIV- and malaria- rapid diagnostic test kits, condoms, lubricants, and laboratory reagents to public sector institutions, including teaching hospitals, clinical laboratories, and other not-for-profit private Institutions.